FCGRT and neoplasm: As CAR T cells accumulate at the tumor site, the effective checkpoint blockade Ab they serete can increase localized concentration in situ, in contrast with barrier-restricted entry to systemically delivered Abs, or even intracerebrally delivered Abs, which are actively pumped out by transporters like the neonatal Fc receptor (FcRn) located in the BBB.